It can be also concluded that patients carrying the T allele in their genotype have higher serum levels of MMP-9 compared to patients with the C allele, which would suggest using of MMP-9 as a marker in the pathogenesis of MS. The gene discussed is MMP9; the disease is myeloid sarcoma.